Inhibitors of angiogenesis: Ready for prime time?

Nov 10, 2017 by in RHEUMATOLOGY Comments Off on Inhibitors of angiogenesis: Ready for prime time?

Abstract Angiogenesis plays a crucial role in the pathogenesis of inflammatory diseases, including rheumatoid arthritis (RA). Therefore, targeting neovascularization in RA may hold great therapeutic potential. Several mediating factors are…

read more

Mesenchymal stromal cells for treatment of arthritis

Nov 10, 2017 by in RHEUMATOLOGY Comments Off on Mesenchymal stromal cells for treatment of arthritis

Abstract Patients with refractory inflammatory arthritis can still respond favourable to autologous haematopoietic stem cell transplantation. However, this treatment has a high morbidity and even 5% mortality. Mesenchymal stromal cells…

read more

Epigenetic changes: The missing link

Nov 10, 2017 by in RHEUMATOLOGY Comments Off on Epigenetic changes: The missing link

Abstract The association of rheumatoid arthritis (RA) with a number of genetic risk loci is well established; however, only part of the risk to develop the disease is based on…

read more

Stroma: Fertile soil for inflammation

Nov 10, 2017 by in RHEUMATOLOGY Comments Off on Stroma: Fertile soil for inflammation

Abstract Biological therapies for the management of immune mediated inflammatory diseases such as rheumatoid arthritis have proven to be extremely successful in recent years. Despite these successes, even the most…

read more

Molecular and cellular heterogeneity in the Rheumatoid Arthritis synovium: Clinical correlates of synovitis

Nov 10, 2017 by in RHEUMATOLOGY Comments Off on Molecular and cellular heterogeneity in the Rheumatoid Arthritis synovium: Clinical correlates of synovitis

Abstract Rheumatoid Arthritis is characterized by autoimmune-mediated attack of the joint synovial lining resulting in destruction of bone and cartilage, and is a clinically and biologically heterogenous disease with respect…

read more
Get Clinical Tree app for offline access